Table 3.
Myosteatosis and survival from date of treatment start
| Parameter | No‐myosteatosis (n = 51) | Myosteatosis (n = 72) | P value |
|---|---|---|---|
| Progression free survival | |||
| #Events/at risk | 44/51 | 53/72 | |
| Median (mo) | 4.0 | 11.0 | |
| Age‐adjusted | Referent | 0.49 (0.32‐0.75) | .001 |
| Adjusteda | Referent | 0.53 (0.34‐0.83) | .005 |
| Overall survival | |||
| #Events/at risk | 41/51 | 49/72 | |
| Median (mo) | 9.8 | 15.3 | |
| Age‐adjusted | Referent | 0.58 (0.38‐0.89) | .013 |
| Adjusteda | Referent | 0.57 (0.36‐0.91) | .018 |
Abbreviations: BMI, body mass index; ECOG, Eastern Cooperative Oncology Group Performance.
a
Cox model adjusted for age (continuous), weight loss (<5%, 5‐9.9, or >9), BMI (<18.5, 18.5‐24.9, 25‐30, or >30), and ECOG (0, 1, or 2).